255
Participants
Start Date
January 28, 2019
Primary Completion Date
November 7, 2022
Study Completion Date
August 23, 2024
brentuximab vedotin
1.2 mg/kg by IV infusion
doxorubicin
25 mg/m\^2 by IV infusion
vinblastine
6 mg/m\^2 by IV infusion
dacarbazine
375 mg/m\^2 by IV infusion
G-CSF
Granulocyte colony stimulating factor (G-CSF) primary prophylaxis administered 24-36 hours after each dose of A+AVD
nivolumab
240 mg by IV infusion
Epworth Healthcare, Victoria
Monash Medical Centre, Clayton
Ballarat Regional Integrated Cancer Care, Ballarat
Royal Adelaide Hospital, Adelaide
Mount Sinai Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino
Clinical Research Alliance - Abraham Mittelman, MD, LLC, Purchase
Clinical Research Alliance - Morton Coleman, MD, Westbury
New York Oncology Hematology, P.C., Albany
Hospital Universitario de Girona Doctor Josep Trueta, Girona
Virginia Cancer Specialists, PC, Fairfax
Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care, Salem
Azienda Ospedaliera Spedali Civili di Brescia, Brescia
IRCSS Policlinico San Matteo, Pavia
Wake Forest Baptist Medical Center / Wake Forest University, Winston-Salem
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Puerta de Hierro Majadahonda, Majadahonda
Medical University of South Carolina/Hollings Cancer Center, Charleston
Hospital Universitario Central de Asturias, Oviedo
Miami Cancer Institute at Baptist Health, Inc., Miami
Florida Cancer Specialists - North Region, St. Petersburg
Hospital Clinico Universitario de Salamanca, Salamanca
Tennessee Oncology-Nashville/Sarah Cannon Research Institute, Nashville
University of Tennessee, Knoxville
Toledo Clinic Cancer Center, Toledo
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic, The, Cleveland
Oncology Hematology Care, Cincinnati
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Karmanos Cancer Institute / Wayne State University, Detroit
Henry Ford Health System, Detroit
Azienda Ospedaliera Universitaria Senese, Siena
Minnesota Oncology Hematology P.A., Edina
Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood
Illinois Cancer Specialists, Niles
Illinois Cancer Care, Peoria
Washington University in St Louis, St Louis
Texas Oncology - Flower Mound, Flower Mound
Texas Oncology - Medical City Dallas, Dallas
Texas Oncology - Northeast Texas, Tyler
Texas Oncology - Fort Worth 12th Avenue, Fort Worth
Brooke Army Medical Center, Fort Sam Houston
Texas Oncology - San Antonio Medical Center, San Antonio
Texas Oncology - Austin Midtown, Austin
Rocky Mountain Cancer Centers - Aurora, Aurora
Cancer Centers of Colorado - Denver, Denver
Poudre Valley Health System (PVHS), Fort Collins
University of Colorado Health Memorial Hospital, Colorado Springs
SCL Health - St. Mary's Hospital & Medical Center, Grand Junction
Huntsman Cancer Institute/University of Utah, Salt Lake City
Los Angeles Cancer Network / Compassionate Care Research Group, Fountain Valley
Providence Portland Medical Center, Portland
Willamette Valley Cancer Institute and Research Center, Eugene
Vista Oncology Inc PS, Olympia
Kadlec Clinic Hematology and Oncology, Kennewick
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
New Jersey Hematology Oncology Associates, LLC, Brick
Regional Cancer Care Associates - Freehold, Freehold
Hackensack University Medical Center, Hackensack
Regional Cancer Care Associates - Howell, Howell Township
Morristown Medical Center/ Carol G. Simon Cancer Center, Morristown
Regional Cancer Care Associates - Mount Holly, Mount Holly
Regional Cancer Care Associates - Central Jersey, Somerville
Regional Cancer Care Associates - Sparta, Sparta
CareMount Medical Group, Mount Kisco
MD Anderson Cancer Center / University of Texas, Houston
Seattle Cancer Care Alliance / University of Washington, Seattle
Fakultni nemocnice Hradec Kralove-oddeleni klinicke hematologie, Hradec Králové
Fakultni Nemocnice Kralovske Vinohrady, Prague
Pratia MCM Krakow, Krakow
Hospital del Mar, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Institut Catala d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), Barcelona
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Seagen Inc.
INDUSTRY